COMMUNIQUÉS West-GlobeNewswire

Consolidated Sales Of Olainfarm In 2018 Exceed 124 Million, Marking The New Record
28/02/2019
Consolidated profit and loss calculation of JSC Olainfarm for 2018 shows that with the sales worth more than 124 million euros the Group has set the new annual sales record. In 2018 the net profit of Olainfarm Group [...]
ImmuCell Announces Submission of Manufacturing Technical Section for its Purified Nisin Product
28/02/2019
PORTLAND, Maine, Feb. 28, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Dr. Mehmet Oz and Daphne Oz to host inaugural Sharecare Awards
28/02/2019
Marlo Thomas, Dr. Sanjay Gupta, American Red Cross and Atlanta Police Foundation to be recognized with special honors at celebratory event ATLANTA, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Sharecare, the digital health company [...]
Amniotic Stem Cell Co-culture System Significantly Promotes Wound Healing
28/02/2019
Merakris Therapeutics’ Lead Scientist, Sam Fagg MSc, PhD, Presents the Research Triangle Park-based Company’s Amniotic Stem Cell Co-culture RALEIGH, NC, Feb. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Merakris [...]
VIRBAC - Mise en conformité du contrat du liquidité
28/02/2019
Le 28 février 2019 Virbac et Exane Bnp Paribas ont signé un nouveau contrat de liquidité (le « Contrat 2019 »), entré en vigueur le 1er janvier 2019, à la suite des évolutions de la réglementation applicable aux [...]
The Alliance for Regenerative Medicine Releases 2018 Annual Data Report, Highlighting Sector Trends and Metrics
28/02/2019
WASHINGTON, D.C., Feb. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today announced the release of its 2018 Annual Data Report, offering an in-depth look at trends and [...]
Delcath Joins the Ocular Melanoma Community in Recognizing Rare Disease Day
28/02/2019
NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, highlights the experiences of [...]
PCI Biotech: Resignation of Chief Business Development Officer
28/02/2019
Oslo (Norway), 28 February 2019 - PCI Biotech (OSE: PCIB), a cancer focused biopharmaceutical company today announced that its Chief Business Development Officer (CBDO), Gaël L’Hévéder has resigned and will leave PCI [...]
Hemispherx Announces Dutch Health Inspectorate Approval to Extend the Ampligen Pancreatic Cancer Early Access Program Until March 2020
28/02/2019
OCALA, Fla., Feb. 28, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in [...]
Chemesis in Colombia: The Place to Be for South American Cannabis, Plus Exclusive CEO Interview -- CFN Media
28/02/2019
SEATTLE, Feb. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel Bispecific Antibodies
28/02/2019
Abpro eligible to receive up to $4 billion, including $60 million in near-term R&D funding, plus potential milestones and royalties Collaboration to result in multiple new immuno-oncology bispecific therapeutic [...]
CTD Holdings Announces Grant to U.S. Non-Profit Organization to Support Patient Participation in Informational Meetings with Regulators
28/02/2019
Support is part of CTD’s efforts to recognize Rare Disease Day 2019 ALACHUA, Fla., Feb. 28, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin- [...]
Apellis Pharmaceuticals Announces Collaboration with SFJ Pharmaceuticals® for APL-2 in Hematologic Indications
28/02/2019
Apellis to receive up to $120 million in upfront and near-term milestone payments, with the potential for additional payments subject to mutual agreement Apellis retains exclusive worldwide commercial rights to APL-2 in [...]
On “Grindeks” results in 2018
28/02/2019
Turnover of Grindeks reaches 145.5 million euros in 2018 Today, on 28 February, the JSC “Grindeks” submitted the non-audited consolidated financial statements of 2018 to Nasdaq Riga. Non-audited financial results [...]
Loos, France, RLG Headquarter, February 28th 2019 : ISOVITAL - Radiopharma Logistics Group (RLG) ; AFAQ ISO 9001-2015 certification successfully renewed for the “organization of transport for radioactive and hazardous materials”.
28/02/2019
Following the Jan 2019 AFAQ audit, Isovital is pleased to announce that is AFAQ ISO 9001 V2015 was successfully renewed until Fev 2022, for the “organization of transport for radioactive and hazardous materials”. [...]
Loos, France, siège d'Isovital, 28 février 2019 : ISOVITAL - Radiopharma Logistics Group (RLG) ; renouvellement de la certification AFAQ 9001-2015 pour « l’organisation de transport de matières radioactives et dangereuses ».
28/02/2019
Suite à l’audit de janvier 2019, Isovital est heureux d’annoncer le renouvellement de sa certification AFAQ 9001-2015 pour « l’organisation de transport de matières radioactives et dangereuses » Philippe Sueur, [...]
Todos Medical Raises $1,350,500 In Funding and Finalizes Joint Venture Agreement with Amarantus Bioscience
28/02/2019
JV to focus on the development of Alzheimer’s blood diagnostic LymPro Test 2.0 REHOVOT, Israel and NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics [...]
Aura Announces Signing of Definitive Share Purchase Agreement to Acquire Licenced Medical Cannabis Distributor in Germany
28/02/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION OR DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Feb. 28, 2019 ( [...]
RECORDATI: BOARD APPROVES THE 2018 ACCOUNTS. SALES € 1,352.2 MILLION (+5.0%), EBITDA € 499.1 MILLION (+9.8%), OPERATING INCOME € 442.2 MILLION (+8.8%) AND NET INCOME € 312.4 MILLION (+8.2%). 2018 DIVIDEND € 0.92 (+8.2%)
28/02/2019
RECORDATI: BOARD APPROVES THE 2018 ACCOUNTS. SALES € 1,352.2 MILLION (+5.0%), EBITDA € 499.1 MILLION (+9.8%), OPERATING INCOME € 442.2 MILLION (+8.8%) AND NET INCOME € 312.4 MILLION (+8.2%). 2018 DIVIDEND € 0.92 (+8.2 [...]

Pages